Senores Pharmaceuticals Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Senores Pharmaceuticals (SENORES) Key Ratios
Senores Pharmaceuticals Share Price Analysis API (Live)
Senores Pharmaceuticals share price is ₹1,482.10, day high (share price) is ₹1,494.00, day low (share price) is ₹1,466.20 and volume is 84,500. 52 Week high share price for Senores Pharmaceuticals is ₹1,599.00 on 24 Aug 2026 and 52 week low share price for Senores Pharmaceuticals is ₹632.05 on 11 Aug 2025. Price data as of: 28 Aug, 2026 3:31 PM.
According to latest price data (as of 28 Aug, 2026 3:31 PM) for Senores Pharmaceuticals share, 14 day period RSI (Relative Strength Index) is 56.1, 50 DMA (50 Displaced Moving Average) is 1,402.28 and 200 DMA (200 Displaced Moving Average) is 997.84.
Senores Pharmaceuticals (SENORES) Technical Analysis
Senores Pharmaceuticals Technical Data and Analysis available in multiple timeframes.
Senores Pharmaceuticals Oscillators Analysis
Senores Pharmaceuticals Price Action
Senores Pharmaceuticals Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 56.13 |
| Stoch %K (14, 3, 3) | 52.13 |
| CCI (20) | 23.59 |
| ADX (14) | 27.56 |
| Awesome Osc | 68.78 |
| Momentum (10) | 4.40 |
| MACD (12, 26, 9) | 35.21 |
| MACD Signal | 40.62 |
| Stoch RSI (14) | 16.19 |
| Williams %R (14) | -62.11 |
| Bull/Bear Power | -5.10 |
| Ultimate Osc | 39.35 |
| MFI (14) | 73.23 |
| ROC (21) | 14.68 |
| ROC (125) | 90.20 |
| ATR (14) | 56.48 |
Senores Pharmaceuticals Moving Averages
| Ichimoku Base | 1,439.35 | Above Base |
| VWMA (20) | 1,457.08 | Above VWMA |
| HMA (9) | 1,471.73 | Above HMA |
Senores Pharmaceuticals Technical SWOT Analysis
STRENGTHS
- Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
- Price is above the 50 DMA, suggesting supportive medium-term trend structure.
- RSI at 56.13 reflects mild positive momentum.
WEAKNESSES
- No notable technical weakness signals are currently observed.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- No immediate technical risk signals are identified.
Senores Pharmaceuticals Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 1,523.13 | 1,516.30 | 1,489.75 | 1,508.57 |
| Resistance 2 | 1,508.57 | 1,505.15 | 1,487.20 | 1,497.95 |
| Resistance 1 | 1,495.33 | 1,488.50 | 1,484.65 | 1,491.39 |
| Pivot Point | 1,480.77 | 1,477.35 | 1,482.10 | 1,480.77 |
| Support 1 | 1,467.53 | 1,460.70 | 1,479.55 | 1,470.15 |
| Support 2 | 1,452.97 | 1,449.55 | 1,477.00 | 1,463.59 |
| Support 3 | 1,439.73 | 1,432.90 | 1,474.46 | 1,452.97 |
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Senores Pharmaceuticals - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 45.82% | 45.82% | 45.80% | 45.80% |
| FII | 6.62% | 3.64% | 3.35% | 4.28% |
| DII (Other) | 3.21% | 4.54% | 4.44% | 5.08% |
| Retail & Others | 37.79% | 40.93% | 41.54% | 41.31% |
| Mutual Funds | 6.56% | 5.07% | 4.88% | 3.54% |
Senores Pharmaceuticals - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 679.69 +62.8% | 159.10 +125.45% | 121.52 +108.3% |
| Mar 2025 | 417.51 +92.1% | 70.57 +182.85% | 58.34 +78.36% |
| Mar 2024 | 217.34 +457.0% | 24.95 +100.56% | 32.71 +288.02% |
| Mar 2023 | 39.02 | 12.44 | 8.43 |
